rs4567343

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_001438.4(ESRRG):c.589+27553C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene ESRRG is a tumor suppressor gene (CancerMine: 5 TSG, 2 oncogene citations). The gene ESRRG is a known oncogene (CancerMine: 5 TSG, 2 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000659 (AC=1) in the gnomAD database across 151,830 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000242. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)

Consequence

ESRRG
NM_001438.4 intron

Predictors

3
AlphaGenome AVI: 0.6 : Benign

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.469

Publications

4 publications found
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001438.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000024, AC = 1 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001438.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ESRRG NM_001438.4
MANE Select
HGVSc / HGVSpc.589+27553C>T
Exon rankIntron 3 of 6
intron
Prot: NP_001429.2
ESRRG NM_001243518.2
HGVSc / HGVSpc.604+27553C>T
Exon rankIntron 4 of 7
intron
Prot: NP_001230447.1UniProt: P62508-5
ESRRG NM_001134285.3
HGVSc / HGVSpc.520+27553C>T
Exon rankIntron 5 of 8
intron
Prot: NP_001127757.1UniProt: P62508-2

Ensembl Transcripts

ESRRG ENST00000408911.8
TSL:1MANE Select
HGVSc / HGVSpc.589+27553C>T
Exon rankIntron 3 of 6
intron
Prot: ENSP00000386171.3UniProt: P62508-1
ESRRG ENST00000366937.5
TSL:1
HGVSc / HGVSpc.604+27553C>T
Exon rankIntron 4 of 7
intron
Prot: ENSP00000355904.1UniProt: P62508-5
ESRRG ENST00000359162.6
TSL:1
HGVSc / HGVSpc.520+27553C>T
Exon rankIntron 4 of 7
intron
Prot: ENSP00000352077.2UniProt: P62508-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
AF: 0.00000659
AC:1
Hom:0
AN:151830
Cov:31
GnomAD4 genome
AF: 0.00000659
AC:1
Hom:0
AN:151830
Cov:31
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:1539
AN:21682
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign0.59
BayesDel_noAF
Benign-0.88
CADD
Benign0.96
DANN
Benign0.92
GPN-Star LLR
N/A-0.17
GPN-Star score
N/A-0.17
PhyloP100
Benign-0.47
Showing 7 of 7 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.